Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06755359 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2026 to Mar 1, 2026
    • Site details revised at 12 of 12 sites
    v4
  2. Start date: Apr 2025 to Jan 2026v3
  3. Start date: Jan 2025 to Apr 2025v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment including radioactive sources named Alpha DaRT sources: Ra - 224 coated onto stainless steel tubes inserted into the tumor for the treatment of Locally Advanced Pancreatic Cancer .
Trial Details
NCT Number NCT06755359
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Related terms Pancreatic Neoplasms
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov